Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

palbociclib 75 MG Oral Capsule

Known as: PALBOCICLIB 75MG CAP,ORAL, PALBOCICLIB 75MG CAP,ORAL [VA Product], PALBOCICLIB 75MG ORAL CAP 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
PD0332991 (palbociclib/Ibrance®) is a cyclin-dependent kinase (CDK)4/6 inhibitor that has recently been approved for the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5